TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.20
0.28 (2.82%)
At close: Sep 26, 2025, 3:59 PM
11.00
7.84%
After-hours: Sep 26, 2025, 07:36 PM EDT
2.82% (1D)
Bid | 10.1 |
Market Cap | 8.5M |
Revenue (ttm) | n/a |
Net Income (ttm) | -24.6M |
EPS (ttm) | -61.43 |
PE Ratio (ttm) | -0.17 |
Forward PE | -1.2 |
Analyst | Buy |
Dividends | n/a |
Ask | 11 |
Volume | 26,639 |
Avg. Volume (20D) | 90,336 |
Open | 10.00 |
Previous Close | 9.92 |
Day's Range | 9.86 - 10.47 |
52-Week Range | 6.15 - 739.20 |
Beta | 1.47 |
Ex-Dividend Date | n/a |
About RNAZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNAZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNAZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-21.22%
TransCode Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
4 months ago
-9.18%
TransCode Therapeutics shares are trading lower after the company announced a 1-for-28 reverse stock split